SNTI
Senti Biosciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website entibio.com
- Employees(FY) 122
- ISIN US81726A1007
Performance
+3.24%
1W
+27.33%
1M
-7.1%
3M
-1.85%
6M
-42.12%
YTD
-61.1%
1Y
Profile
Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Technical Analysis of SNTI 2024-05-10
Overview:
In analyzing the technical indicators for SNTI over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-12 20:15
- 2024-05-09 10:55
- 2024-05-09 04:05
- 2024-04-29 20:05
- 2024-03-21 10:53
- 2024-03-21 04:05
- 2024-01-05 03:05
- 2023-12-25 22:32
- 2023-12-21 23:12
- 2023-12-21 17:30
- 2023-11-13 03:15
- 2023-11-06 18:54
Why Is Senti Biosciences (SNTI) Stock Up 140% Today?(Investorplace)
- 2023-11-06 03:05
- 2023-10-30 21:06
- 2023-09-26 21:05
- 2023-09-26 04:05
Senti Bio to Participate in Upcoming Conferences(Yahoo Finance)
- 2023-09-04 20:30
Senti Bio to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2023-08-10 21:50
- 2023-08-10 20:35
- 2023-08-09 20:35
- 2023-06-04 20:04
- 2023-05-19 20:05
- 2023-05-09 04:05
- 2023-05-02 04:45
- 2023-04-16 20:45
- 2023-04-13 21:00
Senti Bio to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2023-03-22 05:09
- 2023-03-14 04:35
- 2023-02-05 17:26
- 2023-02-03 03:05
Senti Biosciences Announces New Employment Inducement Grants(Yahoo Finance)
Page 1 of 2
previousnext